Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
Single dose of Pfizer vaccine may be sufficient for nursing home residents who had COVID-19: preliminary...
By
Amy Novotney
Apr 16, 2021
Amid the temporary halt in the long-term care industry’s use of Johnson & Johnson’s COVID-19 vaccine, new research suggests that a single dose of the Pfizer vaccine may provide sufficient immunity...
Clinical briefs for Monday, March 29
By
Alicia Lasek
Mar 29, 2021
Thirty-day COVID mortality declines in nationwide elder veterans study … Women accumulate Alzheimer’s tau protein in the brain faster than men, research shows … Nearly all healthcare workers...
Clinical briefs for Friday, Feb. 26
By
Alicia Lasek
Feb 26, 2021
Fauci seeks therapies for long-lasting COVID-19 symptoms … ‘Real-world’ trial of Pfizer vaccine finds 93% protection at two doses … White House HHS nominee challenged on home state’s pandemic...
Clinical briefs for Monday, Feb. 22
By
Alicia Lasek
Feb 22, 2021
Pfizer vaccine’s deep-freeze storage and second shot may be unnecessary … For-profit nursing homes are ‘worst performers’ in COVID infection control analysis … Researchers pinpoint too-low diastolic...
Don’t rule out COVID-19 soon after vaccination, study in healthcare workers suggests
By
Alicia Lasek
Feb 04, 2021
Clinicians should have a “high level of suspicion” about possible COVID-19 symptoms in the two weeks following vaccination, investigators say.
Drugmakers to test vaccine boosters in cautionary step against new COVID strains
By
Alicia Lasek
Jan 27, 2021
Pfizer and Moderna say they are planning to test or develop new booster vaccines in a pre-emptive strike against new coronavirus strains that may make their current COVID-19 vaccines less effective.
CDC: COVID vaccines can be interchanged and doses delayed in supply crunch
By
Alicia Lasek
Jan 26, 2021
The agency has suggested exceptions to its official vaccine rules for cases when supply shortages interrupt second doses.
New report details allergic reactions to early Pfizer-BioNTech COVID-19 vaccinations
By
Alicia Lasek
Jan 25, 2021
Among 21 patients who experienced anaphylaxis in the first days of the rollout, 18 had onset within 30 minutes. Common signs of allergic reaction were hives (urticaria); rapid edema, or swelling beneath...
Biden to speed up vaccinations; second dose shortage unlikely, advisers say
By
Alicia Lasek
Jan 15, 2021
Biden aims to have 100 million vaccines administered in his first 100 days. Meetings with manufacturers have bolstered confidence that supply will steadily increase, an advisory board member said.